Tumor suppressor-like mutations mark a dosage-constrained dependency in leukemia
Jonathan D. Lee, Madison M. Uyemura, Francisca Lamini, Ryan R. Posey, Ellie H. Shin, Amyah C. Harris, Tiziana Ottone, Giulia Cheloni, David Benson Chou, Bon Q. Trinh, João A. Paulo, Daniel Geoffrey Tenen, John G. Clohessy, MT Voso, Timothy Aaron Graubert, Frank John Slack
The paper shows that oncogene-imposed dosage constraints can lead to mutations resembling tumor suppressor loss, which are essential in APL.
bioRxiv · Sep 30, 2026 · PreprintCancer Biology